Safety profile of paediatric COVID‐19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System
Acta Paediatrica · 2023
DOI: 10.1111/apa.16954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, 2023. Verfasst von Victoria Nikitina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pharmacology, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, COVID-19 Vaccines, COVID-19. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aim
To provide further evidence on the safety profile of COVID‐19 vaccines in paediatrics by analysing the spontaneous reports of adverse effects related to these vaccines.
Methods
Reports related to US paediatric population (from 0 to 17 years) vaccinated with authorised COVID‐19 vaccines were extracted from Vaccine Adverse Event Reporting System from December 2020 to 17 November 2022. We conducted a descriptive analysis of Adverse Events Following Immunization (AEFI), calculating reporting rate of serious AEFIs and focusing on myocarditis and Guillain‐Barré Syndrome after mRNA COVID‐19 vaccines.
Results
Overall, 52 720 reports were retrieved: 77% (40541)‐Pfizer‐BioNTech, 19% (10083)‐Moderna, a small proportion for other vaccines 4% (2096). Most of AEFIs were non‐serious and listed in corresponding SPCs. Of serious AEFIs, 96% were related to the Pfizer‐BioNTech vaccine. Roughly 91% (47874) were related to people from 6 to 17 years, a small percentage of 9% (4773) to the younger group (0–5 years). In both groups, most of the reports were related to mRNA vaccines and the percentage of AEFIs experienced by females were similar to males.
Conclusions
Data showed that events most frequently reported were non‐serious and listed in the corresponding SPCs, extending the evidence of safety of COVID‐19 vaccines authorised in the United States in children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Pharmacology, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
- Alma Mater Studiorum University di Bologna, Bologna, Italy.
ORCID-Profile: Victoria Nikitina, Greta Santi Laurini, Nicola Montanaro, Domenico Motola
Zitieren
APA
Nikitina, V., Santi Laurini, G., Montanaro, N., & Motola, D. (2023). Safety profile of paediatric COVID‐19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System. Acta Paediatrica. https://doi.org/10.1111/apa.16954
Vancouver
Nikitina V, Santi Laurini G, Montanaro N, Motola D. Safety profile of paediatric COVID‐19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System. Acta Paediatrica. 2023. doi:10.1111/apa.16954
BibTeX
@article{Nikitina2023,
author = {Nikitina, Victoria and Santi Laurini, Greta and Montanaro, Nicola and Motola, Domenico},
title = {Safety profile of paediatric COVID‐19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System},
journal = {Acta Paediatrica},
year = {2023},
doi = {10.1111/apa.16954}
}
EUVIMED